Skip to main content
MAHMOUD KHATIB A. A. AL-RUWEIDI  · From bench research toward better medicines
A research journal / a personal archiveDrug discovery · therapeutic delivery · biological response

Mahmoud Khatib A. A. Al-Ruweidi Research since 2015 / 11 years

I follow molecules
beyond the flask.

My first research project, in 2015, explored how curcumin could be used to detect cyanide. Since then I have investigated developing blood vessels in zebrafish, the injury caused by mechanical forces on lung cells, and the behavior of engineered materials. Today I study inhalable drug carriers, where a promising formulation must also contend with nebulization and the practical demands of pulmonary delivery.

I trained in chemistry and now pursue research in pharmaceutical sciences, drawing on experimental biology, materials science and computation. I also write about pharmacology and the history of pharmacy. Across these subjects, I am interested in the distance between a plausible scientific explanation and what an experiment can actually establish.

The question guiding my future research: How can therapeutic interventions be designed to act selectively in diseased tissues, overcome biological barriers and produce measurable, predictable changes in cellular function? I want to investigate this through drug discovery, drug delivery and molecular pharmacology, building on my experimental work in chemistry, biomaterials, epithelial injury and inhalable formulations. Read my research direction ↗

How I got here

I organized my first school chemistry exhibition at Doha Independent School in 2009. Before I had access to university laboratories, chemistry had already become something I wanted to investigate rather than simply study. The fox specimen in a later anatomy lesson opened a different set of questions about how living structures worked together. My first research project began in 2015 with curcumin-based sensing of cyanide, work that later contributed to a study published in Analytical Methods in 2019. At university I pursued plant extracts, imines and molecular sensing, learning to distinguish a plausible explanation from what an experiment could establish.

That habit followed me into developing zebrafish vessels, mechanically injured lung cells and experiments with materials that refused to behave as expected. My current MSc work examines dexamethasone niosomes and proniosomes intended for inhalation, where even a promising formulation must confront nebulization and aerosol transport. I am interested in how molecular structure and material preparation influence function, especially where chemical systems meet living tissues. My work approaches that question through chemistry, interfaces, drug delivery and measured biological responses.

Scientific work, personal history and writing محمود خطيب علي عبدالرسول الرويدي
Published in research as Mahmoud K. Al-Ruweidi
Mahmoud Al-Ruweidi photographed in a laboratory coat at Qatar University in 2026
Mahmoud Al-RuweidiResearcher · Pharmaceutical sciences
Portrait, 2026Qatar University / Scientific archive

A two-minute introduction / 02:00

What survives the experiment.

A short film about the questions that stayed with me: a fox specimen on the anatomy table, a microscope from Cairo, a histology preparation that fell apart, developing vessels in zebrafish and lung cells injured when an airway reopens. The story reaches my current work on inhaled medicines.

Original research and personal archive · 2026

What Survives the Experiment · Two-minute documentaryExplore the film ↗

RESEARCH · WRITING · PERSONAL HISTORIES

Choose a chapter.

Research papers, films, personal histories and the people who shaped the work. Choose the thread you want to follow.

Read the complete homepage recordOpen the longer chapters on research, biography and the scientific community.

02 / Selected investigations

What the experiments
actually asked.

Selected projects in pulmonary mechanobiology, developmental imaging, biomaterials, therapeutic design and computational research. Open a case study for the scientific question, methods, publication record and the scope of my contribution.

Original diagram of polymer surface modification, not microscopyCOLLABORATIVE · 2020–21
BIOMATERIALS

Engineering a material's surface

Electrospinning, cold plasma, and the relationship between polymer surfaces and function.

Original diagram of the SLIT2 ROBO therapeutic target landscape
FIRST AUTHOR · 2026

SLIT2–ROBO therapeutics

Patent families, mechanism, and translational development of an oncology target.

Illustration for the IEEE Access fetal echocardiography study; original published ultrasound images and model workflow are in Figures 2 and 3 of the linked paper
CO-FIRST AUTHOR · IEEE ACCESS · 2023

AI for fetal echocardiography

A peer-reviewed CNN–LSTM and stacking-model pilot study for congenital heart disease detection. My documented work includes ultrasound-data preparation, model evaluation and scientific interpretation.

Conceptual formulation diagram, not software output or validated prediction
OPEN-SOURCE SCIENTIFIC SOFTWARE

NanoFormulationDesigner

Python, physicochemical descriptors, material-property databases and reproducible decision-support tools for nanocarrier preformulation, with explicit uncertainty and validation boundaries.

Explore AI & computing portfolio ↗

03 / Bibliography

Selected
publications.

Research in chemical sensing, pulmonary mechanobiology, computational imaging and materials engineering, alongside reviews, pharmaceutical modelling and historical scholarship. Each entry identifies its publication status and links to the relevant scholarly record.

NEW / THE MOVING BIBLIOGRAPHYA film behind every paper.Explore each publication through its scientific question, original research images and source-linked documentary scenes. Visit the scientific film library ↗

An evolving scientific direction

What I want to investigate next.

I want to understand why an intervention that looks promising at the molecular level may fail when it encounters a diseased tissue. My strongest experimental starting points are inhalable drug-carrier formulation and mechanically injured pulmonary epithelium. They raise questions about stability during administration, access to the relevant cells, target engagement and the biological effect of a delivered dose. Work on small molecules, RNA therapies, targeted biologics or engineered cells could investigate different parts of that problem; the choice should follow a laboratory's disease model and expertise, not precede it.

Explore the central research question

The story behind the research

You could begin
with the laboratory.

The early photographs show me in a lab coat, surrounded by friends, notebooks and unfinished work. By then I had organized a school chemistry exhibition in 2009, examined a fox specimen in an anatomy class, and discovered through illness how uncertain medicine can feel from the patient's side. The laboratory gave me instruments and colleagues with whom to pursue questions that had begun much earlier.

A university-era photograph in a lab coat

At the beginning

Personal photographic archive · 2015

University-era photograph near a chalkboard

Learning in public

Personal photographic archive · 2015

Early photograph of a person speaking into a microphone at an academic event

Asking questions

Personal photographic archive · 2015

Before the experiments

But the question
came earlier.

I did not arrive at chemistry with a neat plan to become a pharmaceutical scientist. I arrived with an old habit of asking how things work, and then finding that an answer at one scale was rarely enough.

Personal childhood archive photograph beside a computer
Before university · At the computer
Childhood portrait holding a small figurine
A childhood portrait from the family album

The earlier years

Curiosity came before a discipline.

These photographs belong to a time before I knew what research would demand of me. I was already drawn to the things I could examine for myself, though I had neither the vocabulary of chemistry nor the methods to test my questions. Those came later.

I was born in Egypt and raised in Qatar, where much of my education and scientific life began. It was a third-culture upbringing in the ordinary sense: Egyptian family roots, everyday life in Qatar, and no particular need to separate the two. The curiosity in these photographs followed me into university, where questions gradually became experiments and research. I still want to understand what I observe, even when doing so means learning an unfamiliar method.

2011 / School anatomy

Anatomy introduced a different kind of problem.

In a school anatomy lesson, I examined a fox specimen and could see how the organs occupied the same confined space. I began asking how their positions and connections affected one another, questions I later encountered again in vascular and pulmonary research.

That lesson stayed with me as I later moved between chemical synthesis, biology and engineering. An explanation that works for an isolated measurement may fail in a whole organism. Around the same period, my own illness began, bringing a less voluntary encounter with the uncertainties of medicine. I discuss that experience separately below.

An instructor and students in white laboratory coats examining a fox specimen during a school anatomy lesson.
2011 / School anatomyLearning by direct observation

From fascination to experimental work

The questions grew more precise. The boundaries became less useful.

Chemistry taught me to design and modify molecules. Working with zebrafish vessels and injured lung epithelial cells made me study how those molecules behave within living systems. Developing inhalable drug formulations grew out of those questions.

2015–2018 / CHEMISTRY & COMMUNITYOriginal archive photograph of a rotary evaporator and glassware at Qatar University

The language of matter

Some early experiments with fellow chemistry students involved extracting oils from materials such as myrrh and nutmeg and asking whether they might have medicinal relevance. Those efforts developed into more formal work in synthesis, molecular recognition and chemical sensing. The ACS student chapter and Chem Squad gave those questions a life outside any one laboratory. We kept meeting, comparing results and challenging one another's explanations.

2016–2023 / LIVING SYSTEMSResearch illustration related to original zebrafish vascular-development work

Where molecules meet physiology

Zebrafish vasculature, primary cilia and alveolar epithelial injury forced me to think about scale. A mechanistic hypothesis has to make sense in tissue, under flow and in a living organism. The experimental footage and methods belong beside the claims, not behind them.

2018–TODAY / MATERIALS TO MEDICINESResearch evidence image related to pulmonary epithelial mechanics and drug-delivery context

Getting an intervention to work

Biomaterials, surface modification and pharmaceutical formulations brought the question closer to therapeutic use. My MSc work on inhalable dexamethasone vesicles tests the behaviour of a drug carrier under nebulization and aerosol delivery, where a formulation must confront the physics of its route.

The present question

At the interface of drug discovery and drug delivery.

My interests lie where molecular pharmacology meets pharmaceutical delivery. A target hypothesis raises questions about dose, tissue exposure and the response of living cells. I want those measurements to influence molecular and formulation design from the beginning.

My ambition is to follow a therapeutic problem through its successive constraints. I want to examine the target, question the molecular design, understand transport and cellular response, and test the result in models that reveal where our assumptions fail. A useful scientist should be able to recognize when a chemical problem has become a physiological one, or when an apparent biological failure is really a problem of exposure.

Working with historical medical texts has taught me how easily later certainty can be imposed on earlier practice. A manuscript records an argument or a procedure; it cannot tell us everything that happened when a medicine was used. In the laboratory I apply the same discipline: separate a proposed mechanism from an observed effect, then ask what evidence could distinguish one explanation from another. I cross into another field when the question requires its methods.

Mechanism → molecular design → formulation & transport → biological response → experimental revision
Mahmoud and Mr. Aref Elahmad, his first chemistry teacher, with a certificate after a Grade 10 chemistry festival
Grade 10 chemistry festival · With Mr. Aref Elahmad at Doha Independent School

BEFORE UNIVERSITY / SCHOOL CHEMISTRY

With the teacher who first taught me chemistry.

Mr. Aref Elahmad was my first chemistry teacher. We are pictured after my research presentation at the Grade 10 chemistry festival at Doha Independent School; I am holding the certificate from that day.

I organized my first school chemistry exhibition in 2009. Those school years came before university research and before eosinophilic illness began to change the course of my education.

Read the school science story and see the graduation photograph ↗

Personal experience / Science / Patient support

The other side
of medicine.

2011My experience with eosinophilic gastrointestinal disease begins
2022Two collaborative, published chapters inspired in part by that experience
TodayA personal appeal to support independent patient organizations

“No one should have to become a scientist to find reliable answers about their illness.”

Support patients and research ↗

I have lived with eosinophilic disease for years, through repeated attacks, treatment and interrupted studies.

My experience since 2011

I was a teenager when persistent gastrointestinal illness began affecting my life in 2011. Recurrent vomiting and other difficult symptoms were followed by years of medical investigations and treatment. My history has included eosinophilic gastroenteritis and evaluation of a wider hypereosinophilic picture. It took a toll on ordinary routines, and at times on my education, examinations, and research.

I lived with the burdens of prolonged glucocorticoid treatment, and later found greater stability with a six-food elimination diet. I am not presenting my experience as a model for anyone else's treatment, or claiming that the condition has been cured. It has taught me how far the language of a clinical diagnosis can be from the uncertainty a patient lives with.

The life between diagnoses

I finished high school at sixteen. My father had died, and I had spent a substantial part of my final school year in hospital. I graduated, but the examination results were insufficient for medical school, which was where I wanted to go. I had already become acquainted with medicine from the patient's side, and I had no wish to give up the other side of the consultation desk.

Some attacks became so severe that I could not keep down even water. They disrupted ordinary life and university study in ways an academic record alone cannot convey. Living through them also taught me how much can remain outside a laboratory measurement.

Severe flares sometimes required urgent investigation and treatment, even when important commitments were approaching. Prolonged treatment brought complications of its own. I describe those episodes in the fuller personal account rather than in this academic overview.

Read the full personal account. My essay The Life Between Diagnoses tells the longer story, including the medical-school path I lost, diagnostic uncertainty, and my experience of prolonged treatment.

Read the chapter on this website ↗ · Read the original essay on Substack ↗

When an experience became scholarship

In 2022, the questions raised by that experience helped inspire two chapters I wrote with colleagues about autoimmune diseases of the gastrointestinal tract. The first covered etiology and pathophysiology; the second examined diagnostics and treatments. These were reviews of the scientific literature, not reports of my own illness. Eosinophilic gastrointestinal disease is not necessarily autoimmune, and I do not equate the two. The chapters are one part of my wider scientific work, but they have particular personal significance.

NOVEMBER 17, 2022 · OPEN ACCESS

Autoimmune Diseases of the GI Tract Part I: Etiology and Pathophysiology

First-listed author with collaborators · IntechOpen

Read the published chapter ↗

NOVEMBER 29, 2022 · OPEN ACCESS

Autoimmune Diseases of the GI Tract Part II: Emergence of Diagnostic Tools and Treatments

First-listed author with collaborators · IntechOpen

Read the published chapter ↗

Independent charities / Official giving links

Help make the next patient's journey less uncertain.

Families affected by eosinophilic diseases need better research and access to specialist care. I have linked the official giving pages of four organizations working on these conditions. Donations go directly to those organizations.

04 / FAMILIES & COMMUNITY

Eosinophilic Family Coalition

US 501(c)(3) · EIN 45-2406486 · Not rated by Charity Navigator

Started as a Cincinnati family support group in 2008. Today it supports families living with eosinophilic disorders through community connections, education and advocacy.

Give directly to EFC Read its mission ↗ Verify 501(c)(3) listing ↗

Independent, verified organizations. APFED and CURED are US 501(c)(3) charities associated with CEGIR patient advocacy; EFC is a separately registered US 501(c)(3) that Charity Navigator lists but does not rate; EOS Network is registered with the UK Charity Commission. All four giving links go directly to the organizations' official websites. I do not collect, receive, or process donations and have no financial relationship with these organizations. Linking them does not imply a formal affiliation or endorsement.

Not in a position to donate? Sharing these official resources, learning about the diseases, or participating in legitimate patient and research communities can also make a difference.

BEYOND THIS PAGE

Science should answer questions patients are actually asking.

I welcome collaborations on patient-facing scientific writing, literature reviews and research communication concerning eosinophilic and related inflammatory conditions. The organizations linked above are independent resources; I am inviting conversations about new work, not speaking on their behalf.

Contact me about patient-focused research communication ↗

Research and clinical information

Learn about the science.

For those interested in the research landscape, the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) ↗ brings together clinical and basic research on eosinophilic gastrointestinal conditions. This is a research-information link, not a separate donation destination.

My account reflects personal experience and is not medical advice. Eosinophilic gastrointestinal diseases are not necessarily autoimmune disorders. None of the organizations listed here sponsors or endorses this personal website.

From the personal history / 2011–2026

Curiosity had a history
before it became a career.

Anatomy lessons in 2011, the creation of QUACS in 2015, international conferences, and laboratory work across the following decade belong to the same story. The photographs bring back the school years, the first university encounters and the laboratories that followed.

Explore the dated photo & video archive ↗
Childhood-era photograph beside a computer
CHILDHOOD · FAMILY ALBUM
Early university-era portrait
EARLY UNIVERSITY · PERSONAL ALBUM

Research philosophy / First principles & systems

Choosing methods
according to the problem.

I have worked on molecular sensors, polymers, vascular imaging and pulmonary drug delivery. Each project required me to learn techniques suited to its particular questions, from spectral characterization to experiments on living cells.

01

Chemistry

Understand matter: synthesis, molecular recognition, structure and reaction.

02

Biomaterials

Engineer matter: polymers, plasma activation, surface properties and interfaces.

03

Bioengineering

Interrogate living systems: mechanical forces, imaging, transport and response.

04

Pharmaceutical sciences

Design interventions: delivery, formulation, exposure and therapeutic consequence.

05

History of medicine

Examine knowledge: what counted as evidence, how medicines were made and why practices endured.

06

Scientific computing

Evaluate evidence: medical AI, biomedical imaging, Python, model-based pharmaceutics and reproducible research software.

Across these fields runs a second concern: building the laboratories, communities and institutions that allow rigorous science to happen.

Explore the experimental methods and original figures ↗ Quality & process thinking ↗

Moving evidence / Animal research

The microscope
records motion.

Zebrafish heart development and optical observation invite a different kind of biological measurement. The Methods Atlas also preserves a short avian egg-preparation recording from the laboratory archive.

04 / Research methods

The work behind
the work.

An experimental record ranging from chemical synthesis and spectroscopy to plasma engineering, cell culture, cardiovascular models, imaging and quantitative biology. The complete atlas connects each technique with a scientific question and published evidence. Explore the full Techniques Atlas ↗

01 / MOLECULES & MATERIALS

Make & modify

Imine synthesis and chemical sensing DIRECT EXPERIMENTAL WORK
Polymeric micelle formulation DIRECT / COLLABORATIVE
Electrospinning and PLA processing DIRECT / COLLABORATIVE
Plasma-assisted surface modification DIRECT / COLLABORATIVE
Niosome / proniosome formulation design ONGOING MSc WORK
02 / BIOLOGICAL MODELS

Observe & perturb

L2 epithelial cell monolayers DIRECT EXPERIMENTAL WORK
Parallel-plate flow chamber, bubble propagation DIRECT EXPERIMENTAL WORK
Live/dead and cytoskeletal fluorescence imaging DIRECT / QUANTITATIVE
Zebrafish embryos, husbandry and phenotyping DIRECT EXPERIMENTAL WORK
High-speed video and vascular hemodynamics APPLIED RESEARCH
Chick-embryo preparation and avian developmental models LABORATORY ARCHIVE
03 / CHARACTERIZATION

Measure & interpret

UV–Vis and fluorescence spectroscopy DIRECT EXPERIMENTAL WORK
ATR-FTIR and Raman spectral interpretation APPLIED ANALYSIS
SEM / AFM and surface-analysis results ANALYSIS / COLLABORATIVE
HPLC assays, DLS and aerosol impactor workflows MSc METHOD DEVELOPMENT
Cancer-cell phenotypes and biomarkers COLLABORATIVE RESEARCH
NMR, GC–MS, ICP–MS, TGA–MS, DSC TRAINING / EXPOSURE
04 / MODELS & METHODS

Analyze & reason

Python, NumPy, pandas; modeling tools APPLIED COMPUTATIONAL WORK
ImageJ and MicroZebraLab quantitative analysis APPLIED RESEARCH
Biomedical microscopy and imaging-workflow development at QU BRC DIRECT / COLLABORATIVE
Fetal echocardiography: CNN–LSTM, stacking, preprocessing and evaluation CO-FIRST AUTHOR · IEEE ACCESS 2023
Evidence synthesis, patent-family landscaping APPLIED RESEARCH
R, SQL, Tableau; qPCR data interpretation ANALYTICAL EXPERIENCE
Scientific software, physicochemical model kernels and testing OPEN-SOURCE PYTHON PROJECT

Methods are classified by hands-on experimental experience, collaborative analysis, current development and formal training. Explore the AI, scientific computing and data-analysis portfolio ↗

Visual methods index

Observe. Measure. Explain.

Published experimental figures from my coauthored research in cell injury, zebrafish imaging, biomaterials and chemical sensing, alongside clearly identified original conceptual illustrations. Each figure links to its paper and attribution.

Read four original figures: what they show and what they cannot establish ↗

Six figures link to their supporting research context.

Bioimaging · QU Biomedical Research Center

Building the capacity
to see and measure.

At the Biomedical Research Center, I helped develop experimental imaging workflows for work involving zebrafish, pulmonary injury and cardiovascular models. Specimen preparation, image acquisition and analysis all presented different problems. I became especially interested in protocols that another researcher could reproduce, including calibration and the conditions under which images were collected.

Imaging and scientific infrastructure ↗
Conceptual zebrafish illustrationILLUSTRATION · NO CLAIM OF EXPERIMENTAL MICROGRAPH

Qatar University × Medical College of Wisconsin

A research question across institutions.

My zebrafish vascular-development work formed part of a collaboration between Qatar University and the Medical College of Wisconsin. In this recorded seminar, Qatar University Research explores the opportunities and challenges of international research partnerships through that collaboration.

Institutional seminar · Qatar University Research · February 2023

Watch the full recording on YouTube ↗

Research awards · QNRF UREP

Four projects.
One developing research trajectory.

My undergraduate grant-supported research connected polymer chemistry, pulmonary cell biomechanics, bioengineered scaffolds and heterocyclic molecular design. The dedicated case pages document research aims, methods, project records and the scope of my contribution as a student researcher.

Explore research awards ↗

Research practice / Quality & process improvement

When a method works,
can it work again?

I do not see quality management as paperwork added after the science. Whether I am working with a synthesis, an inhaled formulation, a microscopy workflow or an organisational process, I want to know where variation enters, how it is measured and whether the result can be reproduced.

Lean and Six Sigma give that thinking a practical structure. They help separate a recurring process fault from random fluctuation, make a change testable and preserve what was learned. They do not replace chemical or biological mechanism; they help build a more dependable experimental system around it.

DMAIC / A process-improvement lens on experimental scienceRigor is designed into the workflow.
  1. 01 / QUESTION

    Define

    Specify a useful endpoint: dose, image quality, assay reliability or cycle time.

  2. 02 / BASELINE

    Measure

    Characterise variability, measurement error and process conditions.

  3. 03 / CAUSALITY

    Analyse

    Distinguish plausible mechanisms from artefacts and process drift.

  4. 04 / DESIGN

    Improve

    Test changes to formulations, protocols or hand-offs using evidence.

  5. 05 / REPEATABILITY

    Control

    Document checks, traceability and limits that keep the method dependable.

Illustrative application of the established DMAIC framework to research and operations, not a claimed completed Six Sigma project or clinical validation result.

Selected professional development / 2021–2025

Credentials behind the practice.

I have also studied quality management, including SOPs, process mapping, document control, KPIs and audit preparation. My training certificates are listed with their issuing organizations; they are individual qualifications, not institutional accreditations.

AIGPE · March 2025

Lean Six Sigma — Green Belt

WhiteYellowGreen

Three issuer-specific belt records. Green Belt programme: 17.5 CPD/CEU hours in the supplied credential record.

IBS · March 2021

ISO 9001:2015 · Quality management

QMS professional training · 15 hours / three days.

Laboratory standards

ISO/IEC 17025:2017

Professional development in testing and calibration laboratory competence.

Environmental systems

ISO 14001:2015

Training in environmental management systems.

Food & operational systems · IBS 2021

ISO 22000 / FSSC 22000

Additional training in food-safety management systems and process assurance.

These are training and issuer-specific credential records, not ASQ Certified Six Sigma Green Belt (CSSGB) status, ISO auditor accreditation or certification of an organisation. The DMAIC illustration is an original typographic graphic, not a certificate scan.

View quality credentials in my academic profile ↗ · View dated course-completion records ↗

A selective chronology

The route through the laboratories.

2009

Chemistry research at school

At Doha Independent School, I began working on chemistry research and organized the school's first chemistry exhibition.

2011

Anatomy at school

Examining a fox specimen makes biological structure tangible years before I enter a research laboratory.

2015–16

A chemistry community forms

Qatar University's ACS student chapter is established in 2015. Early university laboratory work and the independent Chem Squad conversations take shape by 2016.

2017

Research beyond campus

Student-chapter representation and research presentations at the 254th ACS National Meeting in Washington, DC, documented in contemporary reporting.

2018–21

From vessels to cell injury

Published work spans zebrafish endothelial cilia and cardiovascular imaging, pulmonary epithelial mechanobiology, molecular sensing and modified polymer surfaces. I complete my BSc in Chemistry in 2021.

2022

Graduate pharmaceutical sciences

I begin the MSc in Pharmaceutical Sciences at Qatar University, building towards experimental work in pulmonary formulations and drug delivery.

2023–24

New methods, continuing work

Peer-reviewed fetal-echocardiography machine learning appears in 2023. Materials and nanotextile work also become part of the research record.

2025–26

Back to formulation research

I return to graduate study in 2025. Work on inhalable vesicles continues alongside scientific computing, research writing and the 2026 SLIT2–ROBO patent review.

2027 · expected

MSc completion

The master's thesis remains in progress. Completion in 2027 is an expectation, not an awarded degree or a published experimental outcome.

05 / History of pharmacy & medicine

Medicines have histories.
Evidence has contexts.

I began studying history alongside chemistry because the origin of an idea matters as much to me as the mechanism of a molecule. Historical pharmacy lets me ask what physicians, pharmacists and patients believed a medicine should do, how they made it reproducible, and how material constraints shaped practice.

My historical work begins with what a surviving text actually says and how it was used. In studying medieval pharmacy, I examine instructions for preparation, substitution and storage in their original context, then compare them cautiously with modern pharmaceutical questions.

View historical scholarship ↗
IN PRESS · HISTORY OF PHARMACY
صناعة الدواء وحفظه

Making Medicines Keep

Set in Ayyubid–Mamluk Cairo, this study follows Abū al-Munā Dāwūd ibn Abī Naṣr al-Kūhīn al-ʿAṭṭār, a Jewish pharmacist whose Minhāj al-dukkān illuminates the practical decisions behind preparing, substituting and preserving medicines. Formulary texts and surviving prescription evidence reveal how therapeutic reliability was negotiated in practice.

MAHMOUD K. AL-RUWEIDI ET AL. · HISTORY OF PHARMACY AND PHARMACEUTICALS · RESEARCH IN THE HISTORY OF PHARMACY
FORTHCOMING · MEDICINES, PHARMACISTS AND THE PRACTICES OF MEDIEVAL CAIRO

A research film / 02:00 / Accepted article

How did a medicine remain dependable?

The film interprets historical pharmacy through manuscript-based archival material and explanatory visuals. Watch the full historical-pharmacy documentary ↗

INDEPENDENT SCIENTIFIC CIRCLE · 2016–PRESENT

CHEM
SQUAD.

Seven chemistry graduatesWeekly scientific discussionsIndependent collaboration

Some of the most enduring research conversations began with us in an organic chemistry laboratory in 2016.

Our early interests included extracting and studying botanical oils from materials such as myrrh and nutmeg. Today, seven chemistry graduates still meet weekly to exchange scientific ideas, debate research and keep that curiosity alive. Along the way, some members also helped establish Majales Education.

Meet Chem Squad and read our story ↗

08 / Building beyond the laboratory

Ideas need institutions
to become useful.

One lesson from scientific research is that having knowledge and making it accessible are different problems. I have also worked in education, scholarly community-building, and the design of organizations that help people learn and act.

I am a co-founder and partner in Majales, which is still in its initial founding round. Zawya is another early-stage education and knowledge project. My work in these initiatives centres on developing programmes and the research behind them; they are not substitutes for the laboratory work.

Discuss collaboration ↗
CO-FOUNDER & PARTNER · EARLY FOUNDING ROUND

Majales
& Zawya

Co-founding and early-stage partnership in knowledge and educational initiatives. Working through the initial founding round, with an emphasis on concept development and research-led community building.

PRODUCT DIRECTION / EDUCATION / COMMUNITY / RESEARCH-TO-PRACTICE

09 / Teaching & scientific community

Make the laboratory
less distant.

Building a student scientific chapter taught me something that publications alone could not: access to equipment, experienced researchers and a serious scientific community can change what a student believes is possible. I have remained involved in practical training, research mentoring and scientific events while pursuing research of my own.

My work also includes scientific communication and educational entrepreneurship through Majales and Zawya, writing for DDO, and a continuing independent chemistry circle dating back to 2016. Chem Squad reflects the part of research that begins with friendship, curiosity and weekly discussion. We still meet to think aloud about questions that may never become formal projects.

2015–19

Founded the ACS student chapter at Qatar University

Served two years as chapter president and subsequently as adviser, developing chemistry outreach, visiting lectures, practical workshops and travel opportunities for students.

2017–19

International chapter representation

Supported delegations and represented student chemistry work at ACS national meetings in Washington, Boston and San Diego.

Later work

Biomaterials conference and scientific programming

Organised a biomaterials-focused conference and contributed to scientific presentations, specialist workshops and interdisciplinary dialogue.

2023–26

Teaching, mentoring and peer community

Research mentoring, science education and co-founding Arabs in Bio(medical) Engineering, alongside professional and research-methodology workshops.

2026

Research assessment and editorial service

Judging student research, peer-review activities and writing about research practice and the attribution of scientific contributions.

From the chapter archive / 2015–2019

A chapter was never
just a title.

In 2015, I helped establish Qatar University's American Chemical Society student chapter with other students. We organized lectures and public demonstrations, introduced students to laboratory techniques and worked on opportunities to attend international chemistry meetings. I spent much of those years arranging events, contacting speakers and bringing students into the activities.

2015 / Founding

Building the chapter

The chapter was recognised in December 2015. I served as president for two years, followed by an advisory role during its development.

Training / Students

Learning to use the instruments

Coordinated Central Laboratories Unit instrumentation training for 29 students and practical research-methodology sessions.

Talks / Outreach

Chemistry beyond lectures

Chem Talks, public demonstrations, mechanochemistry activities, the Time 0s astrochemistry event and a lecture by historian of chemistry Eric Scerri.

2017–2019 / International

Taking students into the field

Chapter trips and research presentations associated with ACS meetings in Washington, Boston and San Diego. The 2017 Washington participation is independently documented.

The chapter's Instagram archive preserves contemporary photographs and announcements from these student-led activities. Explore documented science engagement ↗

10 / Academic profile

A scientist formed
by different
disciplines.

My central interest is the movement from molecular design to biological function and, eventually, practical therapeutic performance.

My background includes chemistry, pharmaceutical sciences, biomaterials, biological systems, computational approaches and scholarly historical research. The connections between these areas matter more to me than the labels alone.

Read academic CV ↗
Education

MSc Pharmaceutical Sciences
Qatar University · Thesis in progress, expected 2027

BSc Chemistry
Qatar University · 2021
Minor: History of Arab and Islamic Civilization

Current focus

Pulmonary pharmaceutics, therapeutic delivery systems, formulation science and mechanistic drug discovery.

Historical work

Arabic and Islamic pharmaceutical history, material practices, primary texts and the interpretation of medical knowledge.

Across disciplines

Materials chemistry · Molecular sensing · Mechanobiology · Zebrafish biology · Biomedical imaging · Translational research · History of pharmacy.

Location

Qatar · International research and collaboration

Geographies of a scientific life

Three places.
One evolving perspective.

My roots are Egyptian. I grew up and became a scientist in Qatar. Across the Atlantic, the United States represents scientific encounters, research conversations and opportunities to collaborate. These places are not interchangeable chapters; each has shaped a different part of how I understand the world.

Egypt, Qatar, and the United States — three geographical anchors A simplified equirectangular world map. Egypt marks family roots; Qatar marks growing up, education and scientific formation; the United States marks scientific networks and future research possibilities. Lines represent connections and ideas, not measured travel routes or institutional appointments. Select a country marker to highlight its story. UNITED STATES Scientific connections EGYPT Roots QATAR Formation ATLANTIC / MEDITERRANEAN / GULF NOT TO SCALE AS A JOURNEY

This is a map of personal and intellectual connections, rather than an itinerary or a record of institutional appointments. Select any place to follow its thread.

Explore the stories behind the research ↗

World coastlines adapted and simplified from GSHHG (Wessel & Smith, 1996; LGPL). Geographic connections are schematic.

Research / Evidence file